Cabaletta Bio, Inc.
CABANasdaqCIK 1759138HealthcareFiscal year ends Dec 31
Reports and events: 137 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1408:00 ET | 8-K | 8.01 Other events | 0001759138-26-000041 |
| 2026-08-1307:34 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001759138-26-000039 |
| 2026-08-1307:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759138-26-000038 |
| 2026-06-1107:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001759138-26-000033 |
| 2026-06-0307:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001759138-26-000030 |
| 2026-05-1407:08 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001759138-26-000026 |
| 2026-05-1407:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759138-26-000025 |
| 2026-05-1407:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001759138-26-000024 |
| 2026-05-0406:40 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-202446 |
| 2026-05-0406:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-202389 |
| 2026-04-2807:31 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001193125-26-183557 |
| 2026-04-2007:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001759138-26-000016 |
| 2026-03-2307:36 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001759138-26-000011 |
| 2026-03-2307:32 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759138-26-000010 |
| 2026-01-1208:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-26-009819 |
| 2025-11-1007:37 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-273280 |
| 2025-11-1007:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-273272 |
| 2025-10-2907:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-254610 |
| 2025-10-2707:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-250676 |
| 2025-10-0912:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-235533 |
| 2025-09-0306:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759138-25-000007 |
| 2025-08-0707:41 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104573 |
| 2025-08-0707:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104570 |
| 2025-06-1206:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-139517 |
| 2025-06-1106:11 ET | 8-K | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-138737 |
| 2025-06-1017:49 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-137954 |
| 2025-05-1917:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-074589 |
| 2025-05-1507:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-071971 |
| 2025-05-1507:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-071966 |
| 2025-05-1308:00 ET | DEF 14A | Proxy statementPeriod 2025-06-09 | 0001193125-25-118330 |
| 2025-03-3107:16 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-047201 |
| 2025-03-3107:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-047196 |
| 2025-02-1813:03 ET | 8-K/A | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-028420 |
| 2025-02-1807:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-028143 |
| 2025-01-1308:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-005016 |
| 2024-11-1807:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-260425 |
| 2024-11-1407:14 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-126733 |
| 2024-11-1407:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-126731 |
| 2024-10-0706:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-233294 |
| 2024-09-3016:30 ET | 8-K | 1.01 Entry into a material agreement | 0000950170-24-110389 |
| 2024-08-0807:25 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093325 |
| 2024-08-0807:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-196467 |
| 2024-06-1406:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-161089 |
| 2024-06-0416:32 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-154309 |
| 2024-05-1507:53 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-060045 |
| 2024-05-1507:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-138874 |
| 2024-04-2307:00 ET | DEF 14A | Proxy statementPeriod 2024-06-03 | 0001193125-24-105870 |
| 2024-03-2107:24 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-034422 |
| 2024-03-2107:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-073294 |
| 2024-03-2007:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-072048 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 11:27 ET. Listed shows no prices and gives no investment advice.